Details of the Drug
General Information of Drug (ID: DMW0HXO)
Drug Name |
Azithromycin-N-benzyltriazolylnonahydroxamic Acid
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | Azithromycin-N-benzyltriazolylnonahydroxamic Acid; CHEMBL509089; SCHEMBL14329756; BDBM27183; triazole-linked azithromycin-based compound, 16g | |||||||||||||||||||
Indication |
|
|||||||||||||||||||
Structure | ||||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 5 | Molecular Weight (mw) | 1063.4 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 6.3 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 19 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 7 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 18 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References